Data
Year of publication
2020
Type
Quantitative
Design
Animal study
Classification
N/A
Country studied
N/A
Data
Primary
Data Collected
Other
Study setting
Laboratory
Age group of participant
Rats/6-67 days
Participant sex
Male
Target population
N/A
Sample size
n=52 (wistar rats)
Nicotinamide riboside reduces cardiometabolic risk factors and modulates cardiac oxidative stress in obese Wistar rats under caloric restriction
Goal
Investigate the effects of nicotinamide riboside (NR), isolated or combined with caloric restriction (CR).
Results
In obese rats, treatment with NR alone mitigated final body weight gain, reduced adiposity (visceral and subcutaneous), improved insulin resistance, and decreased TG/HDL ratio and heart size. For rats under caloric restriction, treatment with NR increased antioxidant capacity via glutathione peroxidase and catalase enzymes and reduced the pro-oxidant complex NADPH oxidase. Hyperglycemia, hypertriglyceridemia and elevated levels of TBARS in the heart were state-dependent adverse effects, induced by treatment with NR.
Authors
Macedo de Castro J, Fagundes Assumpção JA, Stein DJ, Toledo RS, Silva LS, Caumo W, Carraro CC, Rosa Araujo AS, Torres I.
Journal
Life Sciences
DOI